GELITA will showcase its rebranded Controlled Release Portfolio of performance products
for superior softgels at CPhl in Milan, Italy (October 08-10). This includes RXL® Ultra for
substantially zero crosslinking – even with challenging, plant-based fills. Expert speakers
will explain how to overcome these challenges in their theatre presentation, while GELITA
Health representatives will be on hand throughout the event to show own label customers
how to achieve success in the vibrant collagen supplements market with GELITA Bioactive
Collagen Peptides (BCP®).
Visitors to booth 10G72 can explore the advantages of GELITA’s newly rebranded Controlled
Release Portfolio. Enabling manufacturers to choose when and where in the body softgel fills
are released, it comprises:
- DELASOL®: the only product on the market that creates enteric softgels in a single step,
with no need for additional coating, making production more efficient, - RAPISOL®: for when rapid fill release is the goal,
- RXL® Portfolio, including RXL® Ultra: for reduced crosslinking, no matter how challenging
the fill.
“We have streamlined and strengthened the branding across our Controlled Release
Portfolio to highlight each product’s particular benefits,” explains Dr Stephan Hausmanns,
Head of Global Marketing & Innovation Management at GELITA Performance Solutions. “This
will also enable us to add additional brands to the portfolio as we develop further
innovations in the future. Stay tuned for more to come.”
September 2024 GELITA AG – Uferstraße 7 – 69412 Eberbach, Germany 2
Alongside its Controlled Release Portfolio, GELITA will present EASYSEAL®, a ground-breaking
gelatin that dramatically reduces leakers during softgel production and beyond.
No More Crosslinking: Product Innovation Presentation
In their session at 1:45 p.m. on October 8 (Manufacturing & Outsourcing Theatre, Hall 5),
GELITA experts Dennis Witthoeft and Dr Katrin Kaspar will discuss “Heavy Crosslinking due to
novel Plant Extracts – Challenge Accepted with RXL® Ultra”. RXL® Ultra sets a benchmark in
anti-crosslinking performance. It maintains the known benefits of softgel gelatin while
solving even the most extreme crosslinking challenges. The result is reliable products with
superior stability and shelf-life.
Customizable Solutions for Successful Supplements
Those with an interest in private label supplements can explore exciting opportunities with
representatives from GELITA Health. The GELITA subsidiary specializes in producing
customized finished products for private label customers or under GELITA Health global
brands like QYRA®, CH-Alpha®, convitar® and ShapeUp®. All products contain GELITA’s BCP®,
which have scientifically proven targeted functionalities for different needs. They enable
success in the sectors beauty-from-within, mobility and sports nutrition.
To find out more, please visit GELITA booth 10G72 at CPhI and www.gelita.com
